Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 312

Chickenpox / Shingles in Pregnant Women

RCOG Chickenpox in Pregnancy (Green-top Guideline No.13). Last reviewed 2024.

Background Information

Chickenpox and Shingles

Both chickenpox and shingles are caused by varicella-zoster virus (VZV) (human herpesvirus 3):

  • Chickenpox = primary VZV infection
  • Shingles (herpes zoster) = reactivation of VZV from sensory nerve root ganglia, following primary infection

Complications

Maternal consequences:

  • Pneumonia
  • Hepatitis
  • Encephalitis

 

Fetal / baby consequences:

  • Spontaneous miscarriage (only in 2nd and 3rd trimester)

 

  • Fetal varicella syndrome
    • Risk is highest following maternal infection during the first 20 weeks (low risk >20 weeks)
    • Characterised by several congenital anomalies  

 

  • Neonatal varicella
    • May occurs if maternal infection occurs in the month before delivery
    • Maternal infection from 5 days before to 2 days after delivery has the highest risk of severe, disseminated infection

 

  • Shingles in infancy
    • Due to reactivation of latent VZV acquired either in utero (asymptomatic or minimally symptomatic infection) or postnatally.
    • It presents as a dermatomal vesicular eruption, usually within the first year of life.

Guidelines

Chickenpox / Shingles Exposure in Pregnancy

Step 1: determine VZV immunity status

  • If the patient is uncertain or has no previous history of chickenpox → serology testing for VZV antibodies
  • If patient had previous chickenpox or +ve serology → immune to VZV → no further action (note this is not explicitly stated in the guidelines but assumed)

Step 2: treat pregnant women who are NOT immune to VZV and have significant exposure with PEP (post-exposure prophylaxis)

Choice of PEP:

  • 1st line: oral aciclovir / valaciclovir to be given 7-14 days post-exposure
  • 2nd line: IM VZIG to be given within 10 days post-exposure

Pregnant Women Who Develop Chickenpox

  • Symptomatic treatment and hygiene – to prevent secondary bacterial infection

Anti-viral therapy

  • Severe/complicated chickenpox  → IV aciclovir
  • Uncomplicated chickenpox presenting <24 hours after rash onset → oral aciclovir
    • RCOG states offer if >20 weeks gestation, and consider if <20 weeks gestation

Women should avoid contact with potentially susceptible individuals, e.g. other pregnant women and neonates, until the lesions have crusted over. This is usually about 5 days after the onset of the rash.

 

VZIG has no therapeutic benefit once chickenpox has developed; therefore, it should not be used in pregnant women who DEVELOP chickenpox.

VZIG is only used in the context of chickenpox/shingles post-EXPOSURE prophylaxis.

References

Original Guideline

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD